Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest update is out from Talis Biomedical (TLIS).
Talis Biomedical Corporation has struck a retention deal with Interim CFO Rebecca Markovich, offering her $89,250 to stay on board through major corporate transitions like a sale, merger, or dissolution. This move, which will be detailed in the company’s upcoming quarterly report, aims to ensure financial leadership stability during pivotal moments for the company’s future.
Find detailed analytics on TLIS stock on TipRanks’ Stock Analysis page.
